Philip Morris International Inc. (PM) Stock Analysis

Philip Morris International is transforming from a global cigarette leader into a diversified smoke-free nicotine company. Its portfolio now centers on IQOS heated tobacco, ZYN oral nicotine pouches, VEEV e-vapor, and cash-generative Marlboro-led combustibles. The 2026 segment realignment underscores the commercial scale of smoke-free products. PMI benefits from global reach, premium brand equity, FDA-authorized reduced-risk products, and recurring consumable revenue. The investment case rests on continued migration of adult smokers to higher-margin smoke-free alternatives across international markets and a growing U.S. platform.